Pharmacists in Wabash, Indiana


13 Pharmacists found in Wabash
male pharmacist

Dr. Andrew Taylor, PHARMD


Pharmacist
10 John Kissinger Dr, Wabash, IN 46992
260-659-2224    

female pharmacist

Dr. Christine Marie Brockett, RPH


Pharmacist
1601 N Cass St, Wabash, IN 46992
260-563-4033     260-563-3423

male pharmacist

Daniel Monroe Barr, RPH


Pharmacist
1309 N Cass St, Wabash, IN 46992
260-563-1612    



female pharmacist

Emily Renee Foley, PHARMD


Pharmacist
1309 N Cass St, Wabash, IN 46992
260-563-1612    

female pharmacist

Judy Marie Gravenhorst


Pharmacist
1309 N Cass St, Wabash, IN 46992
260-563-1612    

female pharmacist

Kelsey Seabolt


Pharmacist
1309 N Cass St, Wabash, IN 46992
260-563-1612    

female pharmacist

Mrs. Lisa Renee Kroh, RPH


Pharmacist
710 N East St, Wabash, IN 46992
260-569-0044     260-569-2239

female pharmacist

Nancy Stephens


Pharmacist
486 N Cass St, Wabash, IN 46992
260-563-6941    

female pharmacist

Nikki Bajor


Pharmacist
486 N Cass St, Wabash, IN 46992
260-563-6941    

female pharmacist

Rebecca L Meredith, PHARMD


Pharmacist
10 John Kissinger Drive, Pharmacy, Wabash, IN 46982
260-569-2224    

male pharmacist

Steven Eugene Shively, RPH


Pharmacist
487 N Cass St, Wabash, IN 46992
260-563-3183     260-563-8750

male pharmacist

Dr. Trenton Michael Shoda, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
10 John Kissinger Dr., Wabash, IN 46992
260-569-2267    

male pharmacist

Mr. William J Neeser, RPH


Pharmacist
487 N Cass St, Wabash, IN 46992
260-563-3183     260-563-8750


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.